These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian cancer. Lee JM Cancer Treat Res; 2007; 134():375-85. PubMed ID: 17633067 [No Abstract] [Full Text] [Related]
3. [Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data]. Salle B; Gilly FN; Carry PY; Sayag A; Brachet A; Braillon G J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):369-71. PubMed ID: 8360435 [TBL] [Abstract][Full Text] [Related]
4. The role of laparoscopy in the diagnosis and treatment of peritoneal carcinomatosis: a case report. Takizawa BT; Shin EK; Masters L; Lancelle F; Anaf V; Shahabi S Yale J Biol Med; 2001; 74(2):107-10. PubMed ID: 11393262 [TBL] [Abstract][Full Text] [Related]
5. [Peritoneal carcinomatosis of unknown origin]. Marchal N; Gennigens C; Jerusalem G Rev Med Liege; 2012 Nov; 67(11):582-6. PubMed ID: 23346828 [TBL] [Abstract][Full Text] [Related]
6. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer. Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742 [TBL] [Abstract][Full Text] [Related]
7. C225 and PDT combination therapy for ovarian cancer: the play's the thing. Cengel KA; Hahn SM; Glatstein E J Natl Cancer Inst; 2005 Oct; 97(20):1488-9. PubMed ID: 16234556 [No Abstract] [Full Text] [Related]
8. Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients. Passot G; Bakrin N; Roux AS; Vaudoyer D; Gilly FN; Glehen O; Cotte E Eur J Surg Oncol; 2014 May; 40(5):529-535. PubMed ID: 24370285 [TBL] [Abstract][Full Text] [Related]
9. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center. Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283 [TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer. Magge D; Ramalingam L; Shuai Y; Edwards RP; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA J Surg Oncol; 2017 Sep; 116(3):320-328. PubMed ID: 28628712 [TBL] [Abstract][Full Text] [Related]
12. Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. Tempfer CB Med Hypotheses; 2015 Oct; 85(4):480-4. PubMed ID: 26277656 [TBL] [Abstract][Full Text] [Related]
13. HIPEC in ovarian cancer: treatment of a new era or is it the end of the pipeline? Cascales-Campos P; Gil J; Feliciangeli E; Parrilla P Gynecol Oncol; 2015 Nov; 139(2):363-8. PubMed ID: 26091936 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer. Cascales Campos P; Gil J; Parrilla P Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? Honoré C; Goéré D; Macovei R; Colace L; Benhaim L; Elias D J Visc Surg; 2016 Apr; 153(2):101-7. PubMed ID: 26698380 [TBL] [Abstract][Full Text] [Related]